<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01016938</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00043875</org_study_id>
    <nct_id>NCT01016938</nct_id>
  </id_info>
  <brief_title>Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)</brief_title>
  <official_title>Dynamic MRI for Lung Tumor Motion and Lung Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Maryland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radiation treatment for each patient with cancer is designed based on CT scans. We know that
      tumors in the chest and abdomen move when you breathe. Because of this, there can be
      differences between planned treatment and the treatment actually delivered to the body.
      Usually with radiation a safety margin is added to ensure that radiation hits the entire
      tumor. This can damage healthy parts of the body because the exact location of the tumor is
      unknown.

      Magnetic resonance imaging (MRI) is a painless and safe diagnostic procedure that uses a
      powerful magnet and radio waves to produce detailed images of the body's organs and
      structures, without the use of X-rays or other radiation.

      The research doctors are studying to see if the position of a tumor can be tracked using MRI
      scans and tracking sensors placed on the skin. MRI scans and the tracking system used to
      calculate the location and position of the tumor are both FDA approved technologies.

      The research doctors will also use the MRI scans to evaluate any changes in your lung
      function during and following your radiation treatments.

      In this study the participant will undergo a series of MRI scans with and without contrast
      dye.

      This study is being funded through grants from the National Institutes of Health (NIH).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this protocol, we seek to assess whether tumor motion can be inferred using dynamic MRI
      and external surrogates. We propose to (1) investigate the feasibility of tracking the
      real-time tumor position using dynamic MRI and inferring tumor position using external
      surrogates placed on the skin of the subject and (2) determine lung function during and
      following radiation by assessing lung perfusion maps obtained via dynamic MRI with dose maps
      in order to determine image-based biomarkers for lung toxicity following radiation therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Whose Tumor Position is Visible Within ~2mm Using Cine-MRI Scans and External Sensors</measure>
    <time_frame>2 years</time_frame>
    <description>Tumor tracking using cine-MRI and external surrogates with an accuracy of ~ 2mm.
The participants' tumor size/margins were not specficially defined as long as it was visible/measurable on the MRI.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Whose Tumor Motion Could be Tracked Using Dynamic MRI w/ Contrast Post Radiation</measure>
    <time_frame>2 years</time_frame>
    <description>The internal margin (IM) is one half of the peak-to-peak displacement amplitude on 4D-CT images.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">16</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <description>This is a pilot study and there is only one group.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients must be undergoing radiation therapy with or without chemotherapy for thoracic
        and/or abdominal cancers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years old or older

          -  Patients must be undergoing radiation therapy with or without chemotherapy for
             thoracic and/or abdominal cancers.

        Exclusion Criteria:

          -  Pregnant or breast-feeding women are excluded. Negative serum or urine pregnancy test
             prior to study entry is required. Once on the protocol, the patient will be advised
             and expected to implement an accepted and effective method of contraception such as
             oral contraceptives (birthcontrol pill), intrauterine devices (IUDs), contraceptive
             implants under skin or contraceptive injections and condoms with foam.

          -  Patients with kidney disease of any severity or on hemodialysis.

          -  Patients who have metallic dental fillings or other metallic implants.

          -  Patients with known allergies to gadolinium-based contrast agents.

          -  Patients who have difficulty lying flat on their back for extended periods of time
             will be excluded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Warren D. D'Souza, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMMC MSGCC Department of Radiation Oncology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ummc Msgcc</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2009</study_first_submitted>
  <study_first_submitted_qc>November 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2009</study_first_posted>
  <results_first_submitted>December 2, 2015</results_first_submitted>
  <results_first_submitted_qc>April 11, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 18, 2016</results_first_posted>
  <last_update_submitted>April 11, 2016</last_update_submitted>
  <last_update_submitted_qc>April 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland</investigator_affiliation>
    <investigator_full_name>Department of Radiation Oncology</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dynamic Lung MRI</title>
          <description>Lung Tumor Motion and Function</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dynmaic Lung MRI</title>
          <description>Lung Tumor Motion and Function</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Whose Tumor Position is Visible Within ~2mm Using Cine-MRI Scans and External Sensors</title>
        <description>Tumor tracking using cine-MRI and external surrogates with an accuracy of ~ 2mm.
The participants’ tumor size/margins were not specficially defined as long as it was visible/measurable on the MRI.</description>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lung Tumor Motion and Lung Function</title>
            <description>This is a pilot study and there is only one group.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Whose Tumor Position is Visible Within ~2mm Using Cine-MRI Scans and External Sensors</title>
          <description>Tumor tracking using cine-MRI and external surrogates with an accuracy of ~ 2mm.
The participants’ tumor size/margins were not specficially defined as long as it was visible/measurable on the MRI.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Whose Tumor Motion Could be Tracked Using Dynamic MRI w/ Contrast Post Radiation</title>
        <description>The internal margin (IM) is one half of the peak-to-peak displacement amplitude on 4D-CT images.</description>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dynamic Lung MRI</title>
            <description>Lung Tumor Motion and Function</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Whose Tumor Motion Could be Tracked Using Dynamic MRI w/ Contrast Post Radiation</title>
          <description>The internal margin (IM) is one half of the peak-to-peak displacement amplitude on 4D-CT images.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Dynamic Lung MRI</title>
          <description>Lung Tumor Motion and Function</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Warren D'Souza, PhD, MBA</name_or_title>
      <organization>Universtity of Maryland School of Medicine</organization>
      <phone>410-328-7159</phone>
      <email>wdsouza@umm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

